May 2015 Newsletter
Kool & The Gang to Headline WCLC 2015 Gala Dinner
GAIN Programs - European Locations
GAIN Programs - United States Locations
Take part in this important educational initiative, and you will have the opportunity to earn CME credit and gain access to performance improvement activities developed by CHEST, the American Society for Clinical Pathology, the National Comprehensive Cancer Network® (NCCN®), IASLC and The France Foundation.
June 22 2015 | Philadelphia, PA | View Details
June 24 2015 | New York, NY | View Details
June 26 2015 | Durham, NC | View Details
September 18 2015 | Phoenix, AZ | View Details
Active Members will be receiving notice and instructions via email for the IASLC Board of Directors Election on or around June 11, 2015. The email will come from the following email name and address: "IASLC Election Coordinator <email@example.com>." Only active members who paid dues by May 20, 2015 are eligible to vote. The election will end on July 16th, 2015. If you don't see the email announcement on or around June 11, 2015, please check your spam folder or contact Pia Hirsch at firstname.lastname@example.org.
IASLC Regent Heather Wakelee, MD wins ECOG-ACRIN Award
New Webinar - The evolving role of PD-1/PD-L1 inhibitors in the clinical management of NSCLC
June 2015: The International Association for the Study of Lung Cancer (IASLC) and the Journal of Thoracic Oncology (JTO) are pleased to present this feature each month to highlight certain articles of interest. The selected articles each month will be made available to the public for a limited time at the time of print. The articles below from the June issue of JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
Increasing Physical Activity and Exercise in Lung Cancer: Reviewing Safety, Benefits, and Application
This article reviews the available data on the role of exercise and physical activity in the management of lung cancer – an important topic which in my view is not studied as much as it should be. Read IASLC Press Release
FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non–Small-Cell Lung Cancer
Kwon and colleagues demonstrate in an elegant study that FDG uptake on Positron Emission Tomography is predictive of survival and time to recurrence in early stage Non-Small Cell Lung Cancer
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non–Small-Cell Lung Cancer
In the third highlighted manuscript, “Patients selected for definitive concurrent chemo-radiation at high-volume facilities achieve improved survival in stage III non-small cell lung cancer”, Park et al analyzed over 10,000 cases from the US national cancer data base and demonstrated that the survival of stage III patients treated with chemo-radiation in high volume facilities was superior to those treated in other institutions. Interestingly, these results were independent of academic affiliation.
Paul de Leyn
Thoracic Surgeon, Regent for Europe
New Member Discount Offer for ESTS Members
IASLC Exhibit Booth and Joint Session
Invite Your Colleagues to Join IASLC!
Thanks for your membership in IASLC and your support in growing our global team! Invite a Colleague Now
2015 Member Directory is Online Now; Opt-in to Receive a Printed Version
COMPLIMENTARY Fellows/Residents/Students/Trainees Membership – Group Program Registration
Fun Walk – Pancake Breakfast at the World Conference on Lung Cancer
WCLC 2015: Free Attendance for Patients/Survivors!
Are you interested in getting more involved in IASLC?
World No Tobacco Day - May 31, 2015 - Stop Illicit Trade of Tobacco Products
Become an empowered lung cancer hero at the Free to Breathe Lung Cancer Action Summit!
12th International Conference of Asian Clinical Oncology Society (ACOS)
Many cancers are preventable, many are curable and rest are treatable. Asia is the largest continent, houses 60% of world population and has major cancer burden. Asian countries share challenges in terms of cancer types, therefore there is a greater need to collaborate and address the gaps to have better cure and care of cancer patients. Therefore the theme of conference is “Cancer in Asia: Bridging the Gaps”.
The objectives of ACOS includes cancer prevention, epidemiology, statistics, multidisciplinary treatment i.e. surgery, chemotherapy including oriental medicine, radiotherapy, as well as patient care under high grade development of translational research.
The ACOS is the Biennial International Conference, held in one of our various member countries in Asia. Our aim is foster cancer research & treatment in Asia, clinical experience sharing and enhancing professional networks resulting in advancements of data collation and publication to address the needs of oncologists and cancer patients in Asia. Details
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
February 20 - 23 2019Santa Monica, California
April 3 - 5 2019New York, New York
April 10 - 13 2019Geneva, Switzerland